Wagner M. Zago
Chief Tech/Sci/R&D Officer presso PROTHENA CORPORATION PLC
Provenienza dei contatti di primo grado di Wagner M. Zago
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 32 | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.
27
| Subsidiary | Pharmaceuticals: Major | 27 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Wagner M. Zago tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| VIVUS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Chairman | |
| INTERMUNE INC | Biotechnology | Chief Executive Officer Director/Board Member | |
| CIPHER PHARMACEUTICALS INC. | Pharmaceuticals: Other | Director/Board Member | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| KINDRED BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| MALLINCKRODT PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of Virginia | College/University | Graduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree | |
| Stanford University | College/University | Doctorate Degree Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Comptroller/Controller/Auditor | |
| University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin | |
| Temple University (Pennsylvania) | College/University | Graduate Degree Masters Business Admin | |
| The Pennsylvania State University | College/University | Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Doctorate Degree | |
| University of California San Diego | College/University | Masters Business Admin Doctorate Degree | |
| The University of California, San Francisco | College/University | Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| University College Dublin | College/University | Graduate Degree Graduate Degree | |
| ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Public Communications Contact | |
| NUVATION BIO INC. | Biotechnology | Chairman Director/Board Member | |
| CYCLACEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| CADENCE PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer General Counsel | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| Janssen Alzheimer Immunotherapy | Corporate Officer/Principal General Counsel | ||
| Georgetown University | College/University | Undergraduate Degree Graduate Degree | |
| Philadelphia College of Pharmacy | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 41 |
| Irlanda | 5 |
| Canada | 2 |
| Regno Unito | 2 |
| Norvegia | 2 |
Settori
| Health Technology | 29 |
| Consumer Services | 15 |
| Commercial Services | 3 |
| Finance | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 152 |
| Corporate Officer/Principal | 130 |
| Independent Dir/Board Member | 60 |
| Chief Tech/Sci/R&D Officer | 47 |
| Undergraduate Degree | 43 |
Contatti più connessi
| Insiders | |
|---|---|
| Helen Kim | 33 |
| Daniel Welch | 24 |
| Karl Härfstrand | 23 |
| Eliseo Salinas | 22 |
| Lars Ekman | 21 |
| Nancy Lurker | 20 |
| Christopher Henney | 18 |
| Sarah Noonberg | 17 |
| Richard H. Chin | 17 |
| Renee Tannenbaum | 16 |
| Dennis Selkoe | 16 |
| Oleg Nodelman | 15 |
| Carlos Paya | 14 |
| Shane Cooke | 13 |
| Ivan M. Lieberburg | 12 |
- Borsa valori
- Insiders
- Wagner M. Zago
- Connessioni Società
